Patent Foramen Ovale Closure: State of the Art

Patent foramen ovale (PFO) is a common abnormality affecting between 20% and 34% of the adult population. For most people, it is a benign finding; however, in some people, the PFO can open widely to enable paradoxical embolus to transit from the venous to arterial circulation, which is associated wi...

Full description

Bibliographic Details
Main Authors: Joel P Giblett, Lynne K Williams, Stephen Kyranis, Leonard M Shapiro, Patrick A Calvert
Format: Article
Language:English
Published: Radcliffe Medical Media 2020-11-01
Series:Interventional Cardiology: Reviews, Research, Resources
Online Access:https://www.icrjournal.com/articles/patent-foramen-ovale-closure
id doaj-b0b35eff481a4b758dc4333903a978e9
record_format Article
spelling doaj-b0b35eff481a4b758dc4333903a978e92021-10-09T16:03:12ZengRadcliffe Medical MediaInterventional Cardiology: Reviews, Research, Resources1756-14771756-14852020-11-011510.15420/icr.2019.27Patent Foramen Ovale Closure: State of the ArtJoel P Giblett0Lynne K Williams1Stephen Kyranis2Leonard M Shapiro3Patrick A Calvert4Liverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, Liverpool, UKDepartment of Cardiology, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UKDepartment of Cardiology, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UKDepartment of Cardiology, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UKDepartment of Cardiology, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UKPatent foramen ovale (PFO) is a common abnormality affecting between 20% and 34% of the adult population. For most people, it is a benign finding; however, in some people, the PFO can open widely to enable paradoxical embolus to transit from the venous to arterial circulation, which is associated with stroke and systemic embolisation. Percutaneous closure of the PFO in patients with cryptogenic stroke has been undertaken for a number of years, and a number of purpose-specific septal occluders have been marketed. Recent randomised control trials have demonstrated that closure of PFO in patients with cryptogenic stroke is associated with reduced rates of recurrent stroke. After a brief overview of the anatomy of a PFO, this article considers the evidence for PFO closure in cryptogenic stroke. The article also addresses other potential indications for closure, including systemic arterial embolisation, decompression sickness, platypnoea–orthodeoxia syndrome and migraine with aura. The article lays out the pre-procedural investigations and preparation for the procedure. Finally, the article gives an overview of the procedure itself, including discussion of closure devices.https://www.icrjournal.com/articles/patent-foramen-ovale-closure
collection DOAJ
language English
format Article
sources DOAJ
author Joel P Giblett
Lynne K Williams
Stephen Kyranis
Leonard M Shapiro
Patrick A Calvert
spellingShingle Joel P Giblett
Lynne K Williams
Stephen Kyranis
Leonard M Shapiro
Patrick A Calvert
Patent Foramen Ovale Closure: State of the Art
Interventional Cardiology: Reviews, Research, Resources
author_facet Joel P Giblett
Lynne K Williams
Stephen Kyranis
Leonard M Shapiro
Patrick A Calvert
author_sort Joel P Giblett
title Patent Foramen Ovale Closure: State of the Art
title_short Patent Foramen Ovale Closure: State of the Art
title_full Patent Foramen Ovale Closure: State of the Art
title_fullStr Patent Foramen Ovale Closure: State of the Art
title_full_unstemmed Patent Foramen Ovale Closure: State of the Art
title_sort patent foramen ovale closure: state of the art
publisher Radcliffe Medical Media
series Interventional Cardiology: Reviews, Research, Resources
issn 1756-1477
1756-1485
publishDate 2020-11-01
description Patent foramen ovale (PFO) is a common abnormality affecting between 20% and 34% of the adult population. For most people, it is a benign finding; however, in some people, the PFO can open widely to enable paradoxical embolus to transit from the venous to arterial circulation, which is associated with stroke and systemic embolisation. Percutaneous closure of the PFO in patients with cryptogenic stroke has been undertaken for a number of years, and a number of purpose-specific septal occluders have been marketed. Recent randomised control trials have demonstrated that closure of PFO in patients with cryptogenic stroke is associated with reduced rates of recurrent stroke. After a brief overview of the anatomy of a PFO, this article considers the evidence for PFO closure in cryptogenic stroke. The article also addresses other potential indications for closure, including systemic arterial embolisation, decompression sickness, platypnoea–orthodeoxia syndrome and migraine with aura. The article lays out the pre-procedural investigations and preparation for the procedure. Finally, the article gives an overview of the procedure itself, including discussion of closure devices.
url https://www.icrjournal.com/articles/patent-foramen-ovale-closure
work_keys_str_mv AT joelpgiblett patentforamenovaleclosurestateoftheart
AT lynnekwilliams patentforamenovaleclosurestateoftheart
AT stephenkyranis patentforamenovaleclosurestateoftheart
AT leonardmshapiro patentforamenovaleclosurestateoftheart
AT patrickacalvert patentforamenovaleclosurestateoftheart
_version_ 1716830316072534016